Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 42

1.
2.

Clinical features and burden of new onset diabetic foot ulcers post simultaneous pancreas kidney transplantation and kidney only transplantation.

Sharma A, Vas P, Cohen S, Patel T, Thomas S, Fountoulakis N, Karalliedde J.

J Diabetes Complications. 2019 Sep;33(9):662-667. doi: 10.1016/j.jdiacomp.2019.05.017. Epub 2019 May 29.

PMID:
31301954
3.

Elevated obstructive sleep apnoea risk score is associated with poor healing of diabetic foot ulcers: a prospective cohort study.

Maltese G, Fountoulakis N, Drakatos P, Shah D, Patel K, Sharma A, Thomas S, Pengo MF, Karalliedde J.

Diabet Med. 2018 Nov;35(11):1494-1498. doi: 10.1111/dme.13780. Epub 2018 Aug 23.

PMID:
30022522
4.

Glycaemic control and hypoglycaemia benefits with insulin glargine 300 U/mL extend to people with type 2 diabetes and mild-to-moderate renal impairment.

Javier Escalada F, Halimi S, Senior PA, Bonnemaire M, Cali AMG, Melas-Melt L, Karalliedde J, Ritzel RA.

Diabetes Obes Metab. 2018 Dec;20(12):2860-2868. doi: 10.1111/dom.13470. Epub 2018 Aug 30.

5.

Reduced Levels of Anti-Ageing Hormone Klotho Predict Renal Function Decline in Type 2 Diabetes.

Fountoulakis N, Maltese G, Gnudi L, Karalliedde J.

J Clin Endocrinol Metab. 2018 May 1;103(5):2026-2032. doi: 10.1210/jc.2018-00004.

PMID:
29509906
6.

A pragmatic lifestyle modification programme reduces the incidence of predictors of cardio-metabolic disease and dysglycaemia in a young healthy urban South Asian population: a randomised controlled trial.

Wijesuriya M, Fountoulakis N, Guess N, Banneheka S, Vasantharajah L, Gulliford M, Viberti G, Gnudi L, Karalliedde J.

BMC Med. 2017 Aug 30;15(1):146. doi: 10.1186/s12916-017-0905-6.

7.

Successful management of refractory diabetic gastroparesis with long-term Aprepitant treatment.

Fountoulakis N, Dunn J, Thomas S, Karalliedde J.

Diabet Med. 2017 Oct;34(10):1483-1486. doi: 10.1111/dme.13413.

PMID:
28636760
8.

Increased Arterial Stiffness is an Independent Predictor of Renal Function Decline in Patients With Type 2 Diabetes Mellitus Younger Than 60 Years.

Fountoulakis N, Thakrar C, Patel K, Viberti G, Gnudi L, Karalliedde J.

J Am Heart Assoc. 2017 Mar 30;6(4). pii: e004934. doi: 10.1161/JAHA.116.004934.

9.

Perturbations of the anti-ageing hormone Klotho in patients with type 1 diabetes and microalbuminuria.

Maltese G, Fountoulakis N, Siow RC, Gnudi L, Karalliedde J.

Diabetologia. 2017 May;60(5):911-914. doi: 10.1007/s00125-017-4219-1. Epub 2017 Feb 13.

10.

Delayed diagnosis of Pendred syndrome.

Smith N, U-King-Im JM, Karalliedde J.

BMJ Case Rep. 2016 Sep 12;2016. pii: bcr2016215271. doi: 10.1136/bcr-2016-215271.

11.

Improvements in stage of change correlate to changes in dietary intake and clinical outcomes in a 5-year lifestyle intervention in young high-risk Sri Lankans.

Guess N, Vasantharajah L, Gulliford M, Viberti G, Gnudi L, Karalliedde J, Wijesuriya M.

Prev Med. 2016 Sep;90:193-200. doi: 10.1016/j.ypmed.2016.07.011. Epub 2016 Jul 9.

PMID:
27404575
12.

The effect of dietary changes on distinct components of the metabolic syndrome in a young Sri Lankan population at high risk of CVD.

Guess N, Wijesuriya M, Vasantharajah L, Gulliford M, Viberti G, Gnudi L, Karalliedde J.

Br J Nutr. 2016 Aug;116(4):719-27. doi: 10.1017/S0007114516002476. Epub 2016 Jun 30.

PMID:
27358019
13.

A pilot study to evaluate the efficacy of class IV lasers on nonhealing neuroischemic diabetic foot ulcers in patients with type 2 diabetes.

Maltese G, Karalliedde J, Rapley H, Amor T, Lakhani A, Gnudi L.

Diabetes Care. 2015 Oct;38(10):e152-3. doi: 10.2337/dc15-0774. No abstract available.

PMID:
26404934
14.

Beat it early: putative renoprotective haemodynamic effects of oral hypoglycaemic agents.

Gnudi L, Karalliedde J.

Nephrol Dial Transplant. 2016 Jul;31(7):1036-43. doi: 10.1093/ndt/gfv093. Epub 2015 Apr 8.

15.

Diabetes. Excess mortality in well-controlled T1DM without renal disease.

Karalliedde J, Viberti G.

Nat Rev Nephrol. 2015 Mar;11(3):132-4. doi: 10.1038/nrneph.2014.249. Epub 2015 Jan 20.

PMID:
25599623
16.

Diabetes mellitus, a complex and heterogeneous disease, and the role of insulin resistance as a determinant of diabetic kidney disease.

Karalliedde J, Gnudi L.

Nephrol Dial Transplant. 2016 Feb;31(2):206-13. doi: 10.1093/ndt/gfu405. Epub 2014 Dec 30. Review.

PMID:
25550448
17.

Commentary: the birth of microalbuminuria: a milestone in the history of medicine.

Viberti G, Karalliedde J.

Int J Epidemiol. 2014 Feb;43(1):18-20. doi: 10.1093/ije/dyt256. Epub 2013 Dec 27. No abstract available.

PMID:
24374830
18.

Multidimensional LC-MS/MS enables simultaneous quantification of intact human insulin and five recombinant analogs in human plasma.

Chambers EE, Fountain KJ, Smith N, Ashraf L, Karalliedde J, Cowan D, Legido-Quigley C.

Anal Chem. 2014 Jan 7;86(1):694-702. doi: 10.1021/ac403055d. Epub 2013 Dec 17.

PMID:
24345052
19.

Effect of renin-angiotensin system blockade on soluble Klotho in patients with type 2 diabetes, systolic hypertension, and albuminuria.

Karalliedde J, Maltese G, Hill B, Viberti G, Gnudi L.

Clin J Am Soc Nephrol. 2013 Nov;8(11):1899-905. doi: 10.2215/CJN.02700313. Epub 2013 Aug 8.

20.

Effect of spironolactone and amiloride on thiazolidinedione-induced fluid retention in South Indian patients with type 2 diabetes.

Viswanathan V, Mohan V, Subramani P, Parthasarathy N, Subramaniyam G, Manoharan D, Sundaramoorthy C, Gnudi L, Karalliedde J, Viberti G.

Clin J Am Soc Nephrol. 2013 Feb;8(2):225-32. doi: 10.2215/CJN.06330612. Epub 2012 Nov 26.

21.

High prevalence of cardio-metabolic risk factors in a young urban Sri-Lankan population.

Wijesuriya M, Gulliford M, Charlton J, Vasantharaja L, Viberti G, Gnudi L, Karalliedde J.

PLoS One. 2012;7(2):e31309. doi: 10.1371/journal.pone.0031309. Epub 2012 Feb 13.

22.

The putative role of the antiageing protein klotho in cardiovascular and renal disease.

Maltese G, Karalliedde J.

Int J Hypertens. 2012;2012:757469. doi: 10.1155/2012/757469. Epub 2011 Oct 29.

23.

DIABRISK-SL prevention of cardio-metabolic disease with life style modification in young urban Sri Lankan's--study protocol for a randomized controlled trial.

Wijesuriya M, Gulliford M, Vasantharajah L, Viberti G, Gnudi L, Karalliedde J.

Trials. 2011 Sep 26;12:209. doi: 10.1186/1745-6215-12-209.

24.

Circulating vascular progenitor cells and central arterial stiffness in polycystic ovary syndrome.

Dessapt-Baradez C, Reza M, Sivakumar G, Hernandez-Fuentes M, Markakis K, Gnudi L, Karalliedde J.

PLoS One. 2011;6(5):e20317. doi: 10.1371/journal.pone.0020317. Epub 2011 May 31.

25.

Endothelial factors and diabetic nephropathy.

Karalliedde J, Gnudi L.

Diabetes Care. 2011 May;34 Suppl 2:S291-6. doi: 10.2337/dc11-s241. No abstract available.

26.

Proteinuria in diabetes: bystander or pathway to cardiorenal disease?

Karalliedde J, Viberti G.

J Am Soc Nephrol. 2010 Dec;21(12):2020-7. doi: 10.1681/ASN.2010030250. Epub 2010 Nov 4. Review.

27.

Painful foot drop; a presentation of diabetic muscle infarction.

Karalliedde J, Vijayanathan S, Thomas S.

Diabet Med. 2010 Aug;27(8):958-9. doi: 10.1111/j.1464-5491.2010.03060.x.

PMID:
20653755
28.

Circulating vascular progenitor cells in patients with type 1 diabetes and microalbuminuria.

Dessapt C, Karalliedde J, Hernandez-Fuentes M, Prieto Martin P, Maltese G, Dattani N, Atkar R, Viberti G, Gnudi L.

Diabetes Care. 2010 Apr;33(4):875-7. doi: 10.2337/dc09-1468. Epub 2010 Jan 12.

29.

Critical appraisal of the differential effects of antihypertensive agents on arterial stiffness.

Kum F, Karalliedde J.

Integr Blood Press Control. 2010;3:63-71. Epub 2010 Jun 4.

30.

Valsartan improves arterial stiffness in type 2 diabetes independently of blood pressure lowering.

Karalliedde J, Smith A, DeAngelis L, Mirenda V, Kandra A, Botha J, Ferber P, Viberti G.

Hypertension. 2008 Jun;51(6):1617-23. doi: 10.1161/HYPERTENSIONAHA.108.111674. Epub 2008 Apr 21.

PMID:
18426991
31.

ACCORD and ADVANCE: a tale of two studies on the merits of glycaemic control in type 2 diabetic patients.

Karalliedde J, Gnudi L.

Nephrol Dial Transplant. 2008 Jun;23(6):1796-8. doi: 10.1093/ndt/gfn200. Epub 2008 Apr 10. No abstract available.

PMID:
18403430
32.

Future strategies to prevent renal microvascular disease complications in diabetes.

Karalliedde J, Gnudi L.

Future Cardiol. 2008 Jan;4(1):77-83. doi: 10.2217/14796678.4.1.77.

PMID:
19804273
33.
34.
35.

Effect of various diuretic treatments on rosiglitazone-induced fluid retention.

Karalliedde J, Buckingham R, Starkie M, Lorand D, Stewart M, Viberti G; Rosiglitazone Fluid Retention Study Group.

J Am Soc Nephrol. 2006 Dec;17(12):3482-90. Epub 2006 Nov 8.

36.

Evidence for renoprotection by blockade of the renin-angiotensin-aldosterone system in hypertension and diabetes.

Karalliedde J, Viberti G.

J Hum Hypertens. 2006 Apr;20(4):239-53. Review.

PMID:
16452996
37.

Direct regulation of insulin secretion by angiotensin II in human islets of Langerhans.

Ramracheya RD, Muller DS, Wu Y, Whitehouse BJ, Huang GC, Amiel SA, Karalliedde J, Viberti G, Jones PM, Persaud SJ.

Diabetologia. 2006 Feb;49(2):321-31. Epub 2006 Jan 17.

PMID:
16416272
38.

Determinants of response to insulin therapy following failure of oral agents in type 2 diabetes.

Karalliedde J, Smith A, Viberti G.

Diabetes Care. 2005 Oct;28(10):2589-90. No abstract available.

PMID:
16186308
39.

Targeting albumin excretion rate in the treatment of the hypertensive diabetic patient with renal disease.

Krimholtz MJ, Karalliedde J, Thomas S, Bilous R, Viberti G.

J Am Soc Nephrol. 2005 Mar;16 Suppl 1:S42-7.

40.

Aortic pulse wave velocity and albuminuria in patients with type 2 diabetes.

Smith A, Karalliedde J, De Angelis L, Goldsmith D, Viberti G.

J Am Soc Nephrol. 2005 Apr;16(4):1069-75. Epub 2005 Mar 2.

41.

Hypertension and microalbuminuria: risk factors for cardiovascular disease in diabetes.

Karalliedde J, Viberti G.

Curr Hypertens Rep. 2005 Feb;7(1):1-2. No abstract available.

PMID:
15683578
42.

Microalbuminuria and cardiovascular risk.

Karalliedde J, Viberti G.

Am J Hypertens. 2004 Oct;17(10):986-93. Review.

PMID:
15485765

Supplemental Content

Loading ...
Support Center